Charles River

The acquisition is the latest in a series. (Image: iStock)

Charles River acquires analytical CRO

By Melissa Fassbender

Charles River Laboratories has acquired Blue Stream Laboratories, expanding the company’s biologic and biosimilar development capabilities.

Charles River will continue to broaden its early stage portfolio. (Image: iStock)

Charles River: 2016 to be 'robust year'

By Melissa Fassbender

After reporting a successful FY16, Charles River expects a successful new year driven by customer demand and enhanced strategic partnerships.

Charles River seeing more strategic relationships, CEO says

Charles River seeing more strategic relationships, CEO says

By Zachary Brennan

As Big Pharma and biotech companies continue to outsource more of their work, one of the leaders in the preclinical and discovery space – Charles River Laboratories – is seeing more strategic relationships with both large and small clients, CEO James...

Harlan is making a big push to capture some of the NCI grantees by adopting a new pricing plan

Harlan looks to corner NCI grantees lost by Charles River

By Zachary Brennan

News of the discontinuation of the National Cancer Institute’s (NCI) Animal Production Program has led Charles River Laboratories rival Harlan to vie for the market of grantees that still need animal research models.

New Yelp-like website offers insider perspectives on CROs

New Yelp-like website offers insider perspectives on CROs

By Zachary Brennan

The Life Sciences Strategy Group has launched a new website for biopharma outsourcing professionals, which includes a star-based user ratings program for CROs that’s similar to Yelp’s ratings system of restaurants.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers